首页|寄生虫及其相关物治疗炎症性肠病转归进展

寄生虫及其相关物治疗炎症性肠病转归进展

扫码查看
炎症性肠病(IBD)是一种病因尚未完全明确、以肠道症状为主的肠道疾病.该病迁延难愈,为国内外肠道疾病的疑难病,严重影响患者生存质量.近年研究发现,寄生虫及其相关物作用宿主后,可诱导一系列免疫应答,调节免疫微环境及改善肠道菌群,减轻炎症症状.本文就寄生虫及其相关物实验治疗IBD的最新研究进展进行综述,以期为治疗IBD的新型药物研发提供参考.
Advances in the treatment of inflammatory bowel disease with parasites and their agents
Inflammatory bowel disease(IBD)is a type of intestinal disease whose etiology has not been com-pletely defined and is mainly characterized by intestinal symptoms.This disease is protracted and difficult to cure,making it a challenging medical condition both domestically and internationally,and seriously affects the life quality of the patients.Recently,it has been found that parasites and their related agents can regulate the immune microenvi-ronment,improve intestinal flora and reduce inflammatory symptoms by inducing a series of immune responses after acting on the host.In this paper,the latest research advances in the experimental treatment of IBD with parasites and related agents are reviewed to provide a reference for developing new drugs for the treatment of IBD.

ParasiteInflammatory bowel diseaseExperimental treatment

徐凯、陈力、林登峰

展开 >

浙江大学医学院附属邵逸夫医院肛肠外科,杭州 310016

寄生虫 炎症性肠病 实验治疗

浙江省教育厅一般科研项目

Y202249521

2024

中国寄生虫学与寄生虫病杂志
中华预防医学会,中国疾病预防控制中心寄生虫病预防控制所

中国寄生虫学与寄生虫病杂志

CSTPCD北大核心
影响因子:1.155
ISSN:1000-7423
年,卷(期):2024.42(3)